← Open Payments lookup

JACQUE LANGFORD-KARRE: Open Payments

NPI 1174003941 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,309 in 252 payments from 19 companies in 2025. Trend: 2023 $182 · 2024 $3,112 · 2025 $4,309

Food & beverage: $4,199Education: $109
CompanyPaymentsAmount
Janssen Biotech, Inc.70$1,144
ABBVIE INC.35$570
Madrigal Pharmaceuticals28$549
Gilead Sciences, Inc.28$434
GENZYME CORPORATION10$316
Ardelyx, Inc.17$300
Lilly USA, LLC8$241
Takeda Pharmaceuticals U.S.A., Inc.16$225
Phathom Pharmaceuticals, Inc.21$164
Regeneron Healthcare Solutions, Inc.4$95

Products named: TREMFYA, REZDIFFRA, DUPIXENT, IBSRELA, RINVOQ, OMVOH, VOQUEZNA, ENTYVIO.

Industry payments across NE — which companies pay providers there.